Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized Salbutamol for Hyperkalemia in Liver Transplantation
NCT05589441Unknown
- Sponsor
- First Affiliated Hospital of Xi'an Jiaotong University
- Start
- Oct 2022
- Primary completion
- Oct 2023
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial of salbutamol in hyperkalemia (2 arms), sponsored by First Affiliated Hospital of Xi'an Jiaotong University. Primary endpoint: Blood potassium concentration. Status: unknown.
02
Drugs
salbutamol
03
Conditions
hyperkalemia
Beyond the preview
Go deeper on NCT05589441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05589441.